Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,945
Closed -$872K 2040
2026
Q1
$872K Sell
3,945
-69,085
-95% -$16.9M 0.01% 1035
2025
Q4
$18.5M Buy
+73,030
New +$18.3M 0.15% 115
2025
Q3
Sell
-19,172
Closed -$4.61M 1995
2025
Q2
$4.61M Sell
19,172
-20,816
-52% -$4.85M 0.04% 452
2025
Q1
$9.06M Buy
+39,988
New +$8.8M 0.09% 234
2023
Q4
Sell
-31,731
Closed -$6.96M 2020
2023
Q3
$6.96M Buy
31,731
+10,401
+49% +$2.35M 0.07% 303
2023
Q2
$4.8M Buy
+21,330
New +$4.27M 0.04% 458
2022
Q4
Sell
-34,640
Closed -$5.76M 2106
2022
Q3
$5.76M Buy
+34,640
New +$7.05M 0.08% 357
2021
Q4
Sell
-6,507
Closed -$1.33M 2572
2021
Q3
$1.33M Buy
+6,507
New +$1.39M 0.02% 898
2021
Q1
Sell
-2,980
Closed -$565K 2580
2020
Q4
$565K Buy
+2,980
New +$556K 0.01% 1173
2020
Q2
Sell
-20,523
Closed -$2.87M 2015
2020
Q1
$2.87M Buy
20,523
+5,974
+41% +$893K 0.16% 121
2019
Q4
$2.22M Buy
+14,549
New +$2.13M 0.04% 316
2019
Q2
Sell
-42,342
Closed -$5.42M 1313
2019
Q1
$5.42M Buy
+42,342
New +$4.98M 0.4% 42

Other funds holding STE

Michael Gelband's STE Position: Q2 2026 in Review

Michael Gelband sold out of Steris (STE) in Q2 2026, closing a stake of 3,945 shares — an estimated $872K sold.

Michael Gelband first reported a position in STE in Q1 2019 and held it in 12 quarters. The position peaked at $18.5M in Q4 2025. 828 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Michael Gelband reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 3,945 Steris shares in Q2 2026, an estimated $872K.
  • Michael Gelband first reported a position in Steris in Q1 2019 and held it in 12 quarters.
  • Michael Gelband's Steris position peaked at $18.5M in Q4 2025.
  • 828 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.